Application of pharmaceutical composition in preparing medicine for treating cerebral thrombosis

A composition and cerebral thrombosis technology, applied in the directions of drug combination, pharmaceutical formulation, plant raw material, etc., can solve the problem of insignificant function, and achieve the effects of stable drug effect, prevention of cerebral thrombosis, and reasonable drug formulation.

Inactive Publication Date: 2016-07-27
GUANGDONG JUZHICHENG TECH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The pharmaceutical composition has the functions of promoting blood circulation, removing blood stasis, anti-inflammatory and analgesic, but its functions in reducing blood sugar, blood fat and blood pressure, preventing cerebral thrombosis, etc. are not significant

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pharmaceutical composition in preparing medicine for treating cerebral thrombosis
  • Application of pharmaceutical composition in preparing medicine for treating cerebral thrombosis
  • Application of pharmaceutical composition in preparing medicine for treating cerebral thrombosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] The pharmaceutical composition of Example 1 of the present invention is mainly prepared from the following raw materials in parts by weight:

[0032] 12 parts of purslane, 16 parts of Chuanxiong, 14 parts of peach kernel, 12 parts of myrrh, 10 parts of veratrum, 10 parts of Alisma, 8 parts of forsythia, 6 parts of Moringa leaf, 4 parts of Moutan bark and 4 parts of licorice.

[0033] The preparation method is as follows:

[0034] S1: Take purslane, wash away impurities, dry and pulverize, pass through a 80-mesh sieve, add ethanol with a volume fraction of 80% in an amount 10 times the weight of purslane, and extract by microwave for 15 minutes, with a microwave power of 300W and an extraction temperature of 60 ℃, filter and retain the purslane dregs, concentrate the filtrate under reduced pressure to 60 ℃ to measure the extract with a relative density of 1.25, and obtain the purslane extract;

[0035] S2: Take Chuanxiong, peach kernel, myrrh, veratrum, Alisma, forsythi...

Embodiment 2

[0041] The pharmaceutical composition of Example 2 of the present invention is mainly prepared from the following raw materials in parts by weight:

[0042] 26 parts of purslane, 30 parts of Chuanxiong, 26 parts of peach kernel, 16 parts of myrrh, 14 parts of veratrum, 20 parts of Alisma, 16 parts of forsythia, 12 parts of Moringa leaf, 16 parts of Moutan bark and 10 parts of licorice.

[0043] The preparation method is the same as in Example 1.

Embodiment 3

[0045] The pharmaceutical composition of Example 3 of the present invention is mainly prepared from the following raw materials in parts by weight:

[0046] 20 parts of purslane, 24 parts of Chuanxiong, 18 parts of peach kernel, 14 parts of myrrh, 12 parts of veratrum, 16 parts of Alisma, 10 parts of forsythia, 8 parts of Moringa leaf, 6 parts of Moutan bark and 6 parts of licorice.

[0047] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of traditional Chinese medicines and relates to an application of a pharmaceutical composition in preparing a medicine for treating cerebral thrombosis. The pharmaceutical composition is mainly prepared from the following raw materials in parts by weight: 12-26 parts of herba portulacae, 16-30 parts of ligusticum wallichii, 14-26 parts of peach kernel, 12-16 parts of myrrh, 10-14 parts of veratrum nigrum, 10-20 parts of rhizoma alismatis, 8-16 parts of fructus forsythiae, 6-12 parts of moringa leaf, 4-16 parts of cortex moutan and 4-10 parts of liquorice. The pharmaceutical composition provided by the invention has the functions of activating blood and resolving stasis, moving qi and relieving pain, replenishing qi and nourishing blood and the like and also has the functions of melting turbidity and reducing lipid and reducing blood glucose and blood pressure, and realizes remarkable effects on preventing and treating cerebral thrombosis.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, and in particular relates to the application of a pharmaceutical composition in the preparation of medicines for treating cerebral thrombosis. Background technique [0002] Acute cerebrovascular disease is a group of diseases with rapid onset of brain vascular circulation disorders, and is a common and frequently-occurring disease of the nervous system, with high disability and fatality rates. Cerebral thrombosis is one of the three common acute cerebrovascular diseases. The basic cause is the thickening of blood vessels, stenosis and occlusion of the lumen or the formation of thrombus on the basis of stenosis due to atherosclerosis and other autologous diseases, resulting in reduced blood flow or blood supply in the brain. Interrupted, cerebral ischemia and hypoxia lead to softening necrosis and focal neurological symptoms. Common sites of cerebral thrombosis are the internal carotid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/896A61P9/10A61P3/06A61P9/12
CPCA61K36/896A61K36/185A61K36/236A61K36/328A61K36/484A61K36/634A61K36/71A61K36/736A61K36/884A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2236/53
Inventor 邓凤桂
Owner GUANGDONG JUZHICHENG TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap